@cilianjames @JervesX @steph_10g @mmc_im https://t.co/FNPlKVfEJ1 CASSINI trial - rivaroxaban 10mg QD (low dose) not superior to placebo. AVERT trial - eliquis 2.5mg BID significantly reduced VTE events but also significantly increased risk of major bleed
Anticoagulation Strategies in Patients With Cancer https://t.co/DmceGpLlea
RT @datsunian: @md_arianemacedo @linfopedia @Dr_Mike_Fradley Other great reviews... https://t.co/20zehR5Rzl @SarjuGanatraMD @salimhayek @An…
@md_arianemacedo @linfopedia @Dr_Mike_Fradley Other great reviews... https://t.co/20zehR5Rzl @SarjuGanatraMD @salimhayek @AnaBaracCardio & overall AC strategies in cancer https://t.co/4EtnsjIwOD @CardioOncology @netta_doc @HayaseJustin @BrentonBauerMD
RT @JuanCriadoG: ETV y Cáncer. Anticoagulation Strategies in Patients With Cancer | JACC: Journal of the American College of Cardiology h…
ETV y Cáncer. Anticoagulation Strategies in Patients With Cancer | JACC: Journal of the American College of Cardiology https://t.co/bBdcCZolbx
Parte del día a día en la labor del cardiólogo. En quienes y como usar anticoagulación profiláctica sobre todo en población oncológica. https://t.co/bIIQ8VkpNL
RT @FirasElChaer: @Plenary_Session @svenjammin Just listened to this episode & read the JACC A/C guidelines published last month, I found i…
RT @FirasElChaer: @Plenary_Session @svenjammin Just listened to this episode & read the JACC A/C guidelines published last month, I found i…
@Plenary_Session @svenjammin Just listened to this episode & read the JACC A/C guidelines published last month, I found it interesting that this is now advocated for w/o any scrutiny. I'm sure the busy clinician will take these reccs at face value w/o
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @hemomad: #Anticoagulation Strategies in Patients With #Cancer https://t.co/JWzxrwSapP via @onlinejacc https://t.co/ZS9EplQwxP
RT @hemomad: #Anticoagulation Strategies in Patients With #Cancer https://t.co/JWzxrwSapP via @onlinejacc https://t.co/ZS9EplQwxP
RT @hemomad: #Anticoagulation Strategies in Patients With #Cancer https://t.co/JWzxrwSapP via @onlinejacc https://t.co/ZS9EplQwxP
RT @hemomad: #Anticoagulation Strategies in Patients With #Cancer https://t.co/JWzxrwSapP via @onlinejacc https://t.co/ZS9EplQwxP
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @hemomad: #Anticoagulation Strategies in Patients With #Cancer https://t.co/JWzxrwSapP via @onlinejacc https://t.co/ZS9EplQwxP
RT @hemomad: #Anticoagulation Strategies in Patients With #Cancer https://t.co/JWzxrwSapP via @onlinejacc https://t.co/ZS9EplQwxP
RT @Manugrillo2: Anticoagulation Strategies in Patients With Cancer JACC Review Topic of the Week Ramya C. Mosarla, Muthiah Vaduganathan,…
Anticoagulation Strategies in Patients With Cancer JACC Review Topic of the Week Ramya C. Mosarla, Muthiah Vaduganathan, Arman Qamar, Javid Moslehi, Gregory Piazza and Robert P. Giugliano #NOACs https://t.co/ETMlWfYOth https://t.co/1SAF8XZXNZ
RT @hemomad: #Anticoagulation Strategies in Patients With #Cancer https://t.co/JWzxrwSapP via @onlinejacc https://t.co/ZS9EplQwxP
#Anticoagulation Strategies in Patients With #Cancer https://t.co/JWzxrwSapP via @onlinejacc https://t.co/ZS9EplQwxP
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @Echoraljpangio: Anticoagulation Strategies in Patients With Cancer | JACC: Journal of the American College of Cardiology https://t.co/z…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
Anticoagulation Strategies in Patients With Cancer | JACC: Journal of the American College of Cardiology https://t.co/zTfxwsiBkr
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
Estrategias de anticoagulación en ptes oncológicos, un tema que no esta claro en ningún lado https://t.co/X2140w4Hiq #cardiologia #oncocardiologia
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
RT @krychtiukmd: Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology…
Anticoagulation Strategies in Patients With Cancer - great overview on an important topic in #Cardiology and #Oncology #Cardiotwitter #Haematology #Haemostaseology https://t.co/nDFiVCVDay https://t.co/QToLKtxW2N
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
RT @JACCJournals: DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in ca…
DOACs offer a convenient & patient-centric #cvCoag strategy with emerging data supporting their safety and efficacy in cancer. https://t.co/SS8WIEdm6L #JACC https://t.co/Lkm5wA8R5V
RT @CanbolatIP: Kanseri olan hastalarda antikolagulan tedavi yaklaşımı https://t.co/0scNOXKqwq https://t.co/XZY4UZt3FH
Kanseri olan hastalarda antikolagulan tedavi yaklaşımı https://t.co/0scNOXKqwq https://t.co/XZY4UZt3FH
Anticoagulation Strategies in Patients With Cancer https://t.co/ps3mFzeOSg https://t.co/uvEVX0nivf
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @bmprii: An incredibly helpful review on a topic of critical importance in vascular medicine with growing data. This may cover 50% of th…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
Very important!
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
Anticoagulation Strategies in Patients With Cancer https://t.co/a1N2ddQqmH
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @bmprii: An incredibly helpful review on a topic of critical importance in vascular medicine with growing data. This may cover 50% of th…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…
RT @mvaduganathan: Do you use #NOACs to treat AF/VTE or prevent VTE in pts with #cancer? Don't miss an updated primer for cardiologists on…